Verbist J - Search Results

1

Belgian experience with FilterWire EX in the prevention of embolic events during carotid stenting.

Bosiers M, Peeters P, Verbist J, Schroë H, Deloose K, Lauwers G, Stockx L. Bosiers M, et al. Among authors: verbist j. J Endovasc Ther. 2003 Aug;10(4):695-701. doi: 10.1177/152660280301000403. J Endovasc Ther. 2003. PMID: 14533975

2

Selection of treatment for patients with carotid artery disease: medication, carotid endarterectomy, or carotid artery stenting.

Bosiers M, Peeters P, Deloose K, Verbist J, Sprouse RL 2nd. Bosiers M, et al. Among authors: verbist j. Vascular. 2005 Mar-Apr;13(2):92-7. doi: 10.1258/rsmvasc.13.2.92. Vascular. 2005. PMID: 15996363

3

Carotid artery stenting: which stent for which lesion?

Bosiers M, Deloose K, Verbist J, Peeters P. Bosiers M, et al. Among authors: verbist j. Vascular. 2005 Jul-Aug;13(4):205-10. doi: 10.1258/rsmvasc.13.4.205. Vascular. 2005. PMID: 16229793 Review.

4

Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results.

Bosiers M, Deloose K, Verbist J, Schroë H, Lauwers G, Lansink W, Peeters P. Bosiers M, et al. Among authors: verbist j. J Vasc Surg. 2006 Feb;43(2):313-8; discussion 318-9. doi: 10.1016/j.jvs.2005.10.037. J Vasc Surg. 2006. PMID: 16476607 Free article. Clinical Trial.

5

Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures.

Bosiers M, Hart JP, Deloose K, Verbist J, Peeters P. Bosiers M, et al. Among authors: verbist j. Vascular. 2006 Mar-Apr;14(2):63-9. doi: 10.2310/6670.2006.00014. Vascular. 2006. PMID: 16956473

6

Do device characteristics impact outcome in carotid artery stenting?

Hart JP, Peeters P, Verbist J, Deloose K, Bosiers M. Hart JP, et al. Among authors: verbist j. J Vasc Surg. 2006 Oct;44(4):725-30; discussion 730-1. doi: 10.1016/j.jvs.2006.06.029. J Vasc Surg. 2006. PMID: 17011998 Free article.

7

Drug-eluting stents in the management of peripheral arterial disease.

Bosiers M, Cagiannos C, Deloose K, Verbist J, Peeters P. Bosiers M, et al. Among authors: verbist j. Vasc Health Risk Manag. 2008;4(3):553-9. doi: 10.2147/vhrm.s1712. Vasc Health Risk Manag. 2008. PMID: 18827906 Free PMC article. Review.

8

The impact of embolic protection device and stent design on the outcome of CAS.

Bosiers M, Deloose K, Verbist J, Peeters P. Bosiers M, et al. Among authors: verbist j. Perspect Vasc Surg Endovasc Ther. 2008 Sep;20(3):272-9. doi: 10.1177/1531003508323730. Perspect Vasc Surg Endovasc Ther. 2008. PMID: 18930936 Review.

9

AMS INSIGHT--absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis.

Bosiers M, Peeters P, D'Archambeau O, Hendriks J, Pilger E, Düber C, Zeller T, Gussmann A, Lohle PN, Minar E, Scheinert D, Hausegger K, Schulte KL, Verbist J, Deloose K, Lammer J; AMS INSIGHT Investigators. Bosiers M, et al. Among authors: verbist j. Cardiovasc Intervent Radiol. 2009 May;32(3):424-35. doi: 10.1007/s00270-008-9472-8. Epub 2008 Dec 18. Cardiovasc Intervent Radiol. 2009. PMID: 19093148 Free PMC article. Clinical Trial.

10

Two-year outcome after Xpert stent implantation for treating below the knee lesions in critical limb ischemia.

Bosiers M, Lioupis C, Deloose K, Verbist J, Peeters P. Bosiers M, et al. Among authors: verbist j. Vascular. 2009 Jan-Feb;17(1):1-8. doi: 10.2310/6670.2009.00002. Vascular. 2009. PMID: 19344576 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page